News

Latest Dossier - 14.06.2016

The number of publications and patents that involve the CRISPR/Cas system has been increasing exponentially since the technique was first described a few years ago. The increase in funding for projects involving CRISPR/Cas also demonstrates how powerful this new method is. The targeted modification of genomes (also called gene editing or genome editing) using CRISPR/Cas is extraordinarily accurate and also has the potential to cure hereditary diseases. However, the benefits of genome editing raise ethical concerns and involve risks that need to be taken seriously.


New on ...

... Healthcare industry BW

The University of Tübingen is optimising its drug development pipeline. The TuCADD consortium provides professional help to people who want to take potential drug candidates to clinical application. The coaching involves assistance with the entire phase I drug development phase from industry experts.

... Healthcare industry BW

Since 2012, a DFG-funded research group called FOR1680 has been studying CRISPR-Cas, an immune system that unicellular bacteria and arachaea use to protect themselves against attacks from viruses and plasmids. Prof. Dr. Anita Marchfelder, a molecular biologist at Ulm University and coordinator of the FOR1680 research group, and many other researchers were surprised to find that prokaryotes incorporate the genetic material of enemies as a kind of self-vaccination and even pass this protection on to their progeny.

... Bioeconomy BW

In the EU alone, more than 250,000 tons of seashell waste are discarded every year. The exoskeleton of crustaceans consists of proteins, calcium carbonate and chitin, a long-chain sugar molecule which could be used to produce valuable building blocks for the polymer industry. Scientists from the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart have developed a biotechnological process aimed at a sustainable use of this type of waste in the future.

... Bioeconomy BW

Scientists have developed a biotechnological process to produce bacterial alginate. The alginate quality is highly reproducible, making it suitable for the production of fibre-based medicinal products such as wound dressings.

Website address: https://www.bio-pro.de/en/